Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Lundbeck Institute Campus. Go to Lundbeck Institute Campus. Medical education resource center in psychiatry and neurology. Go to channel
Mental health Read time: 2 min Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European... Content action menuShareTestTest 2Test 3
Mental health Read time: 3 min Congress highlights Highlights from ECNP 2021 — Day 3 — October 4th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European... Content action menuShareTestTest 2Test 3
Mental health Read time: 3 min Congress highlights Highlights from ECNP 2021 — Day 2 — October 3rd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European... Content action menuShareTestTest 2Test 3
Mental health Read time: 3 min Congress highlights Highlights from ECNP 2021 — Day 1 — October 2nd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European... Content action menuShareTestTest 2Test 3
Depression Read time: 3 min Satellite symposium Promising data in depression associated with emotional blunting or trauma Treatment for depression should be tailored to individuals’ history and presentation.... Content action menuShareTestTest 2Test 3
Migraine Read time: 2 min Congress highlights Preclinical pearls offer insights into migraine sex differences and sensory thresholds Speaking at #MTIS2020, Professor Frank Porreca, University of Arizona, USA, identified recent... Content action menuShareTestTest 2Test 3
Depression, Schizophrenia Read time: 3 min Congress highlights Why do we need new treatments for major depressive disorder and schizophrenia? Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as... Content action menuShareTestTest 2Test 3
Depression, Schizophrenia Read time: 4 min Congress highlights Lifestyle, the gut, and mental health Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of... Content action menuShareTestTest 2Test 3
Schizophrenia Read time: 3 min Congress highlights Real world study casts new light on potential of polypharmacy The fact that 20-25% of patients with schizophrenia are treated with more than one antipsychotic1... Content action menuShareTestTest 2Test 3
Migraine Read time: 4 min Congress highlights CGRP – new perspectives in headache management Three new takes on the potential for calcitonin gene-related proteins were presented at this year... Content action menuShareTestTest 2Test 3
Migraine Read time: 2 min Article COVID-19 - crisis and migraine management? The current COVID-19 pandemic provides short‑term challenges for migraine management, but can these... Content action menuShareTestTest 2Test 3
Alzheimer's Disease Read time: 2 min Congress highlights Plenty of key targets in the dynamic Alzheimer’s pipeline Far from running dry, the pipeline is well provided with agents in development for Alzheimer’... Content action menuShareTestTest 2Test 3